Phreesia (PHR) stock fell 6.33% after reporting Q2 fiscal 2027 earnings that missed analyst expectations on net income despite beating revenue estimates. While the company posted strong net income growth to $1.9 million ($0.03 per share) and 10% revenue growth to $129.5 million, analysts expected $0.09 per share in earnings. The company maintained full-year guidance and highlighted new products AccessOne and ProviderConnect, but the analyst recommends holding off on investment given the modest performance and ongoing restructuring.
Axe note: Phreesia’s Q2 earnings miss and ongoing restructuring suggest patience over haste for South African investors eyeing healthcare tech exposure.